| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |